Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Before-and-after evaluation of continuous infusion vancomycin in ICU sepsis care
ACTRN12618000314224Phase 4Completed
- Sponsor
- Mr Simon Potts
- Start
- Feb 2015
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of vancomycin in sepsis and bacterial disease (2 arms), sponsored by Mr Simon Potts. Primary endpoints: Hours until therapeutic serum vancomycin concentration, Number of vancomycin courses achieving a therapeutic concentration and 1 more. Started Feb 2015; status: completed.
02
Drugs
vancomycin
03
Conditions
sepsisbacterial disease
Beyond the preview
Go deeper on ACTRN12618000314224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12618000314224.